Bevacizumab in Treating Patients With Persistent or Recurrent Cancer of the Cervix

Clinical trial NCT00025233 · COMPLETED

Trial details

NCT number: NCT00025233
Sponsor: National Cancer Institute (NCI)
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Cervical Squamous Cell Carcinoma Recurrent Cervical Cancer

Start date: 2002-04-01
Primary completion: 2009-07-01
Enrollment: 50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.